(4-Chloro-pyrimidin-2-yl)(2,2,6,6-tetramethyl-piperidin-4-yl)-amine → HCID 57936296, compound
Reaction equation
C([Si](C)(C)[N:6]1[C:14]2[C:9](=[CH:10][CH:11]=[C:12]([CH2:15][CH:16]([NH:18]C(C3C=CC=CC=3)(C3C=CC=CC=3)C3C=CC=CC=3)[CH3:17])[CH:13]=2)[CH:8]=[CH:7]1)(C)(C)C.Cl[C:41]1[CH:46]=[CH:45][N:44]=[C:43]([NH:47][CH:48]2[CH2:53][C:52]([CH3:55])([CH3:54])[NH:51][C:50]([CH3:57])([CH3:56])[CH2:49]2)[N:42]=1>>[NH2:18][CH:16]([CH3:17])[CH2:15][C:12]1[CH:13]=[C:14]2[C:9]([C:8]([C:45]3[CH:46]=[CH:41][N:42]=[C:43]([NH:47][CH:48]4[CH2:53][C:52]([CH3:55])([CH3:54])[NH:51][C:50]([CH3:57])([CH3:56])[CH2:49]4)[N:44]=3)=[CH:7][NH:6]2)=[CH:10][CH:11]=1Participants
3
Procedure
The title compound was prepared as described in Example 215, starting from {2-[1-(tert-butyl-dimethyl-silanyl)-1H-indol-6-yl]-1-methyl-ethyl}-trityl-amine (prepared by trityl and TBDMS protection of 2-(1H-Indol-6-yl)-1-methyl-ethylamine) and (4-chloro-pyrimidin-2-yl)-(2,2,6,6-tetramethyl-piperidin-4-yl)-amine, followed by in situ removal of the protecting groups with 2N-HCl. Yield: 406 mg (31%).
Workup
- customfollowed by in situ removal of the protecting groups with 2N-HCl
Sources & evidence
- ORD record
- ord-b1e73572c6154c068a9bedb44a63ca24
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07615562B2
Reaction notes
Loading…